A study that assessed CXCL10 plasma levels in pSS patients showed that the ratio of full-length (active) CXCL10 to truncated DPP4-truncated (inactive) CXCL10 was significantly increased in pSS patients and provided the highest correlation with disease activity [74]. This evidence concerns the gene DPP4 and peeling skin syndrome.